Adacel

Adacel

File:Adacel.png

Adacel vaccine packaging

Adacel is a vaccine used to protect against tetanus, diphtheria, and pertussis (whooping cough). It is a combination vaccine that is administered to adolescents and adults to boost immunity against these diseases. Adacel is part of the Tdap (tetanus, diphtheria, and acellular pertussis) vaccines.

Composition

Adacel contains inactivated components of the bacteria that cause tetanus, diphtheria, and pertussis. The vaccine is formulated to provide a booster dose of immunity, enhancing the body's defense mechanisms against these infections. The acellular pertussis component is designed to reduce the risk of adverse reactions compared to whole-cell pertussis vaccines.

Indications

Adacel is indicated for use in individuals aged 10 through 64 years. It is particularly recommended for:

• Adolescents and adults who have not previously received a Tdap vaccine.
• Healthcare workers who are in contact with infants.
• Pregnant women, to protect the newborn from pertussis.
• Individuals in close contact with infants younger than 12 months.

Administration

The vaccine is administered as a single intramuscular injection, typically in the deltoid muscle of the upper arm. It is important to follow the recommended immunization schedule to ensure optimal protection.

Side Effects

Common side effects of Adacel include:

• Pain, redness, or swelling at the injection site.
• Mild fever.
• Headache.
• Fatigue.

Serious side effects are rare but can include severe allergic reactions. It is important to monitor for any unusual symptoms following vaccination and seek medical attention if necessary.

Mechanism of Action

Adacel works by stimulating the immune system to produce antibodies against the toxins produced by the bacteria that cause tetanus, diphtheria, and pertussis. These antibodies help neutralize the toxins and prevent the diseases from developing if the individual is exposed to the bacteria in the future.

Storage and Handling

Adacel should be stored in a refrigerator at temperatures between 2°C and 8°C (36°F and 46°F). It should not be frozen, and any vaccine that has been frozen should be discarded. The vaccine should be protected from light and used before the expiration date.

Related Pages

• Vaccine
• Tetanus
• Diphtheria
• Pertussis
• Tdap